Cargando…
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
High expression or aberrant activation of epidermal growth factor receptor (EGFR) is related to tumor progression and therapy resistance across cancer types, including non-small cell lung cancer (NSCLC). EGFR tyrosine kinase inhibitors (TKIs) are first-line therapy for NSCLC. However, patients event...
Autores principales: | Yu, Jiao-jiao, Zhou, Dan-dan, Yang, Xiao-xiao, Cui, Bing, Tan, Feng-wei, Wang, Junjian, Li, Ke, Shang, Shuang, Zhang, Cheng, Lv, Xiao-xi, Zhang, Xiao-wei, Liu, Shan-shan, Yu, Jin-mei, Wang, Feng, Huang, Bo, Hua, Fang, Hu, Zhuo-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374170/ https://www.ncbi.nlm.nih.gov/pubmed/32694521 http://dx.doi.org/10.1038/s41467-020-17385-0 |
Ejemplares similares
-
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation
por: Li, Ke, et al.
Publicado: (2020) -
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription
por: Yu, Jin-mei, et al.
Publicado: (2019) -
Targeting TRIB3 and PML-RARα interaction against APL
por: Li, Ke, et al.
Publicado: (2017) -
TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations
por: Hua, Fang, et al.
Publicado: (2015) -
PML-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia
por: Li, Ke, et al.
Publicado: (2020)